Skip to main content
Glama

search_drugs_fda

Search the FDA's Drugs@FDA database to find approved drug products by brand name, generic name, active ingredient, application number, sponsor, or dosage form.

Instructions

Search Drugs@FDA database for approved drug products

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
sponsor_nameNoSponsor/applicant name
application_numberNoFDA application number (NDA, ANDA, BLA)
brand_nameNoBrand/trade name of the drug
generic_nameNoGeneric name of the drug
active_ingredientNoActive ingredient name
dosage_formNoDosage form
marketing_statusNoMarketing status
countNoField to group results by for counting
limitNoMaximum number of results to return (1-100)
skipNoNumber of results to skip for pagination
Behavior2/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

With no annotations, the description must disclose behavioral traits. It only says 'search,' omitting details on pagination, result format, error handling, or any constraints. The bare minimum is not met.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness3/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is a single sentence, which is concise but overly minimal. It lacks structure or front-loading of key information beyond the basic purpose.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness2/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given 10 parameters, all optional, and no output schema, the description is too sparse. It doesn't explain how to effectively use the search or what results to expect, leaving the agent under-informed.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters3/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema description coverage is 100%, so the baseline is 3. The description adds no additional meaning beyond the schema's parameter descriptions, but it doesn't need to since the schema is self-explanatory.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose4/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states the tool searches the Drugs@FDA database for approved drug products. It uses a specific verb and resource, and while it doesn't explicitly differentiate from sibling tools like search_drug_labels, the name and scope are sufficiently distinct.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines2/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

No guidance is provided on when to use this tool versus alternatives such as search_drug_adverse_events or search_drug_labels. The description lacks any context for appropriate use cases.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Install Server

Other Tools

Latest Blog Posts

MCP directory API

We provide all the information about MCP servers via our MCP API.

curl -X GET 'https://glama.ai/api/mcp/v1/servers/Augmented-Nature/OpenFDA-MCP-Server'

If you have feedback or need assistance with the MCP directory API, please join our Discord server